PrestiBio Rapid Detection Pregnancy Test Midstream REF 100-17 3 TESTS
Published November 1, 2023 · Recall initiated: May 22, 2023
Summary
FDA records medical device Class II recall Z-0055-2024, published November 1, 2023 and initiated May 22, 2023. Recalling firm: Universal Meditech Inc.; Status: Ongoing; Reported quantity: Unknown; Lot: Model Number: 100-17 UDI-DI Code: None Lot Numbers: All products manufactured after March 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS® SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Universal Meditech Inc.
- Distributor
- U.S.: CA, FL, IL, LA, NJ, NY, TX and WY O.U.S.: Taiwan
- Lot
- Model Number: 100-17 UDI-DI Code: None Lot Numbers: All products manufactured after March 2021
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPrestiBio URINALASYS TEST STRIP 10 PARAMETERS REF 900-10November 1, 2023
- FDAPenzeys Brady Street Cheese Sprinkle. Item 20756. net wt 2.2 oz (62g). Penzeys Spices, Wauwatosa, WI 53222.November 1, 2023
- FDAOrganic Protein & 50 Superfoods Protein Powder with Probiotic - Chocolate flavorNovember 1, 2023
- FDASynCardia 50cc TAH-t, Clinical, REF 570500, Sterile EONovember 1, 2023
- FDAKroger Collard Greens packaged in plastic 16oz bag - 8 bags per caseNovember 1, 2023
- FDAMonoject 20 mL Syringe Luer-Lock Tip Soft PackNovember 1, 2023
Questions about this recall
Was PrestiBio Rapid Detection Pregnancy Test Midstream REF 100-17 3 TESTS recalled?
Yes. FDA published recall Z-0055-2024 on November 1, 2023. Reported hazard: Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS® SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit